Hims & Hers Health Announces Director Changes and Compensation Updates
Ticker: HIMS · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1773751
| Field | Detail |
|---|---|
| Company | Hims & Hers Health, Inc. (HIMS) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $100,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: HIMS
TL;DR
HIMS board shakeup: Lytle out, Miller & Cohen in, exec comp changes filed.
AI Summary
Hims & Hers Health, Inc. filed an 8-K on November 21, 2024, reporting changes effective November 15, 2024. The filing details the departure of director Michael J. Lytle and the election of new directors, including Andrew Miller and Dr. Jessica L. Cohen. It also outlines compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy and governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and new appointments, along with changes in executive compensation, can introduce uncertainty regarding strategic direction and operational stability.
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Registrant
- Michael J. Lytle (person) — Departing Director
- Andrew Miller (person) — Elected Director
- Dr. Jessica L. Cohen (person) — Elected Director
- Oaktree Acquisition Corp. (company) — Former Company Name
FAQ
Who has departed from the Hims & Hers Health, Inc. board of directors?
Michael J. Lytle has departed from the board of directors.
Who has been elected as new directors to the Hims & Hers Health, Inc. board?
Andrew Miller and Dr. Jessica L. Cohen have been elected as new directors.
What is the effective date of the changes reported in this 8-K filing?
The earliest event reported is dated November 15, 2024.
What type of information is covered in this 8-K filing besides director changes?
The filing also covers the election of directors and compensatory arrangements of certain officers.
What was the former name of Hims & Hers Health, Inc.?
The former company name was Oaktree Acquisition Corp.
Filing Stats: 782 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2024-11-21 16:28:21
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange
- $100,000 — od and will receive a consulting fee of $100,000. Ms. Autor or the Company may terminate
Filing Documents
- hims-20241115.htm (8-K) — 27KB
- 0001773751-24-000371.txt ( ) — 147KB
- hims-20241115.xsd (EX-101.SCH) — 2KB
- hims-20241115_lab.xml (EX-101.LAB) — 21KB
- hims-20241115_pre.xml (EX-101.PRE) — 12KB
- hims-20241115_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HIMS & HERS HEALTH, INC. Date: November 21, 2024 By: /s/ Oluyemi Okupe Oluyemi Okupe Chief Financial Officer